Hong Kong Healthtech Stock News

SEHK:856
SEHK:856Electronic

Is VSTECS Holdings (SEHK:856) Undervalued Following Its Strong Half Year Earnings?

Why VSTECS Holdings Stock Is Back on Investor Radars After Its Half Year Earnings VSTECS Holdings (SEHK:856) is attracting fresh attention after reporting half year 2026 earnings, with sales of HK$52,610.46 million and net income of HK$914.91 million compared to the prior year period. See our latest analysis for VSTECS Holdings. At a latest share price of HK$9.62, VSTECS Holdings has seen a 1 day share price return of 2.61% and a year to date share price return of 18.91%, while the 1 year...
SEHK:863
SEHK:863Capital Markets

Crypto Stocks Back In Focus With 3 Infrastructure Names Retail Investors Are Tracking

Long term bond buybacks, a softer US dollar and a sharp swing in crypto sentiment have pushed scarce assets such as bitcoin back into the spotlight, along with the stocks tied to that momentum. This shift can reward investors who identify which listed crypto financial infrastructure and trading platforms are most exposed to the news event. This article walks through three such stocks and what their exposure could mean for your portfolio. The stocks covered below are just a sample, and the...
SEHK:1378
SEHK:1378Metals and Mining

China Hongqiao Group (SEHK:1378) Stock Profit Rebound Meets Lingering Market Doubt

China Hongqiao Group stock came into the H1 2026 release looking cheap on traditional metrics, with a trailing P/E well below Hong Kong metals and mining peers and a discounted value on a discounted cash flow comparison. The earnings headline is all about profitability. Net income from continuing operations over the past twelve months reached ¥29,712.981m with a net margin of 16.3%. That combination of a stronger margin profile and a low earnings multiple is now colliding with investor...
SEHK:2268
SEHK:2268Life Sciences

WuXi XDC Cayman (SEHK:2268) Gains Overseas GMP Release, Is The Stock Fully Priced?

WuXi XDC Cayman (SEHK:2268) has reached a new phase in its international build out with its BCM3 dual function production line in Singapore receiving GMP release and moving into global commercial manufacturing. See our latest analysis for WuXi XDC Cayman. Against this backdrop, WuXi XDC Cayman's momentum has been strong, with a 30 day share price return of 28.75% and a year to date share price return of 16.79%. This has contributed to a 1 year total shareholder return of 24.18% at a latest...
SEHK:1024
SEHK:1024Interactive Media and Services

Kuaishou Technology (SEHK:1024) Reports Higher Sales And Lower Profit, Is It Still 37% Undervalued?

Kuaishou Technology (SEHK:1024) reported second quarter 2026 results on 19 August, with sales at CNY 35,535 million and net income at CNY 3,146 million, reflecting higher revenue alongside reduced profitability. See our latest analysis for Kuaishou Technology. Kuaishou Technology’s latest earnings on 19 August, which showed higher sales alongside lower net income, appear to have weighed on sentiment. The stock’s 1-month share price return is down 20.10% and the year to date share price return...
SEHK:1208
SEHK:1208Metals and Mining

MMG (SEHK:1208) Could Be 21% Undervalued As Half Year Earnings Strengthen Its Case

MMG (SEHK:1208) drew fresh attention after reporting half year 2026 sales of US$4,540.1 million and net income of US$897.2 million, while keeping full year copper and zinc production guidance unchanged. See our latest analysis for MMG. MMG's latest earnings release coincides with a sharp pick up in recent momentum, with the stock posting a 10.81% 7 day share price return and a 93.87% 1 year total shareholder return from a HK$9.325 share price today. This suggests that investors are...
SEHK:6993
SEHK:6993Household Products

Blue Moon Group Holdings (SEHK:6993), What Is Behind The Latest Move?

Earnings trigger for Blue Moon Group Holdings stock Blue Moon Group Holdings (SEHK:6993) recently reported half year 2026 results that combined weaker sales with a smaller net loss. This earnings update is an important reference point for how the stock is viewed. See our latest analysis for Blue Moon Group Holdings. The latest half year results appear to have supported improving sentiment around Blue Moon Group Holdings, with a 1-day share price return of 2.47% and a year-to-date share price...
SEHK:1691
SEHK:1691Consumer Durables

JS Global Lifestyle (SEHK:1691) Stock Recovery Relies On Profit Gains Over Revenue

JS Global Lifestyle stock closed at HK$1.575 after a solid run in recent weeks, yet the real story sits in the profit line. H1 2026 delivered basic earnings per share of US$0.003 and net income of US$9.419 million, keeping the recent turn back to profitability intact but at a modest level for a global home appliances player. The market is treating JS Global Lifestyle as a recovery and growth story, helped by a trailing P/E of 15.7x. The key question now is whether this earnings quality...
SEHK:2483
SEHK:2483Consumer Finance

K Cash (SEHK:2483) Stock Highlights Strong EPS As Dividend Questions Linger

K Cash stock closed at HK$1.78 on the day of its H1 2026 report, after a flat month and a slightly softer 90 day run. The headline is not the share price; it is the earnings power behind it. Basic earnings per share for the half came in at HK$0.1022 and trailing twelve month earnings now support a P/E of 9.4x. For a consumer finance stock with a 39.3% net profit margin and a 6.85% dividend yield, this earnings print highlights a time horizon choice. Traders may focus on near term price...
SEHK:1875
SEHK:1875Biotechs

BioDlink International (SEHK:1875) Stock Rebound Meets Shrinking Revenue And Fresh Losses

BioDlink International has been trading like a recovery story, with the stock up about 17% over the past month. However, H1 2026 results underline that this is still a loss making biotech with a valuation built on hope rather than profit. The headline this half is the profit squeeze. Revenue came in at ¥246.011 million, while net income excluding extra items showed a loss of ¥58.517 million and basic earnings per share were also in the red. The share price reaction now rests on how long...
SEHK:9886
SEHK:9886Consumer Retailing

Dingdang Health (SEHK:9886) Stock Slides As Losses Deepen Again

Dingdang Health Technology Group closed at HK$0.78 on the day of its H1 2026 results, with the stock coming off a weak 3 month stretch that left it down about 15%. The headline is not about revenue size for this online pharmacy player. It is about profitability pressure returning, with a reported loss of CNY 64.371 million and basic earnings per share back in the red at CNY 0.05. Short term traders will focus on that setback. Longer term investors will focus on whether the ongoing loss...
SEHK:2499
SEHK:2499Trade Distributors

Folangsi (SEHK:2499) Stock Rich Valuation Meets Thinner Profit Margins

Folangsi stock has been treading water, slipping a few % over the past week and month, even as the latest half year numbers land with a mixed message. The headline is not revenue growth; it is the pressure on profitability. The trailing net profit margin has narrowed to 4.7% while the P/E sits at 20.9x, well above Hong Kong trade distributor peers. That gap between a richer valuation and softer margins is what the market is now pricing in, and it gives every move in the next few sessions...
SEHK:635
SEHK:635Leisure

Playmates Holdings (SEHK:635) Stock Faces Lingering Losses Despite Narrower Deficit

Playmates Holdings went into this H1 2026 release as a high yield toy stock with a stretched valuation on sales and a long record of losses. The share price finished at HK$0.46 on 21 August 2026, leaving the stock down over the past week and quarter, even before investors fully digest the latest numbers. The headline from these results is simple. Revenue landed at HK$267.3m for the half while the company booked a net loss of HK$90.955m and basic earnings per share loss of HK$0.044. For a...